Skip to main content
HR 4242 106th Congress House Health Drug approvals Law Licenses Orphan drugs

Orphan Drug Innovation Act

Introduced: April 11, 2000 See on congress.gov
This bill died when the 106th Congress ended
It never became law before the 106th Congress (1999–2000) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 24, 2000
Referred to the Subcommittee on Health and Environment.
Apr 11, 2000
Referred to the House Committee on Commerce.
Apr 11, 2000
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service
Orphan Drug Innovation Act - Amends the Federal Food, Drug and Cosmetic Act, with respect to orphan drugs, to provide for the waiver of the seven-year prohibition against approval for a drug which is clinically superior to an approved drug.
What's happening now April 24, 2000

Referred to the Subcommittee on Health and Environment.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4242: Orphan Drug Innovation Act. 106th Congress. Open America. https://openamerica.io/bill/106-HR-4242/
MLA
"H.R. 4242: Orphan Drug Innovation Act." 106th Congress, 2026, Open America, https://openamerica.io/bill/106-HR-4242/.
Bluebook (legal)
H.R. 4242, 106th Cong. (2026), https://openamerica.io/bill/106-HR-4242/.
Markdown link
[H.R. 4242: Orphan Drug Innovation Act](https://openamerica.io/bill/106-HR-4242/)
Report a problem